Detail akcie Genoway online

Business Summary: Genoway SA is a France-based company which is specializes in the provision of genetically modified mouse and rat models for biopharmaceutical companies, laboratories and research institutes. The Company offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.
Financial Summary: BRIEF: For the six months ended 30 June 2023, genOway SA revenues increased 20% to EUR9.3M. Net income increased from EUR201K to EUR1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other Charges decrease of 33% to EUR334K (expense), Research Tax Credit increase of 5% to EUR1.7M (income), Extraordinary Income increase of 10% to EUR231K (income).